{"id":"micronized-natural-progesterone","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Breast tenderness"},{"rate":null,"effect":"Mood changes"},{"rate":null,"effect":"Somnolence"}]},"_chembl":{"chemblId":"CHEMBL103","moleculeType":"Small molecule","molecularWeight":"314.47"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Progesterone is a naturally occurring steroid hormone that activates progesterone receptors (PR-A and PR-B) in target tissues. Micronization increases the drug's bioavailability and absorption. The hormone regulates endometrial proliferation, maintains pregnancy, and modulates immune and inflammatory responses in reproductive tissues.","oneSentence":"Micronized natural progesterone binds to progesterone receptors throughout the body to exert hormonal effects on the endometrium, breast, and other reproductive tissues.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:21:20.263Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Endometrial protection in hormone replacement therapy"},{"name":"Luteal phase support / progesterone supplementation"},{"name":"Menopause-related symptoms"}]},"trialDetails":[{"nctId":"NCT05954962","phase":"PHASE4","title":"Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2023-12-23","conditions":"IVF","enrollment":150},{"nctId":"NCT07461909","phase":"","title":"Comparison of Two Vaginal Progesterone Forms in Frozen Embryo Transfer","status":"RECRUITING","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2024-11-08","conditions":"Frozen Embryo Transfer (FET), Infertility, Artificial Cycle","enrollment":400},{"nctId":"NCT06307184","phase":"","title":"Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer","status":"RECRUITING","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2024-02-23","conditions":"Frozen Embryo Transfer","enrollment":530},{"nctId":"NCT04499131","phase":"PHASE4","title":"Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2021-12-09","conditions":"Infertility, Female, ENDOMETRIAL RECEPTIVITY","enrollment":109},{"nctId":"NCT03068910","phase":"EARLY_PHASE1","title":"Hyperandrogenemia and Altered Day-night LH Pulse Patterns","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2016-07-21","conditions":"Hyperandrogenism, Polycystic Ovary Syndrome, Puberty","enrollment":32},{"nctId":"NCT00929006","phase":"EARLY_PHASE1","title":"Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2008-06","conditions":"Puberty, Hyperandrogenism","enrollment":36},{"nctId":"NCT03642665","phase":"PHASE4","title":"Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2018-09-25","conditions":"Embryo Transfer","enrollment":554},{"nctId":"NCT06280560","phase":"","title":"Impact of IVF Hormonal Therapy on Endometrial Receptivity and Endometrial Senescent Cell Pathological Accumulation","status":"RECRUITING","sponsor":"Fundación IVI","startDate":"2024-02-01","conditions":"Endometrial Receptivity","enrollment":60},{"nctId":"NCT05473273","phase":"","title":"Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2023-04-24","conditions":"Infertility, Female","enrollment":40},{"nctId":"NCT03976544","phase":"PHASE4","title":"Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients","status":"TERMINATED","sponsor":"CRG UZ Brussel","startDate":"2019-05-25","conditions":"Miscarriage, Frozen Embryo Transfer, Natural Cycle","enrollment":362},{"nctId":"NCT06644794","phase":"PHASE3","title":"Progesterone-modified Natural Cycle for FET","status":"NOT_YET_RECRUITING","sponsor":"Shandong University of Traditional Chinese Medicine","startDate":"2024-12-05","conditions":"Infertility, Female","enrollment":336},{"nctId":"NCT04092829","phase":"NA","title":"Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer","status":"TERMINATED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2019-09-16","conditions":"Pre-Eclampsia, Frozen Embryo Transfer","enrollment":591},{"nctId":"NCT03803228","phase":"PHASE3","title":"Dual Ovarian Stimulation (DUOSTIM) for Poor Ovarian Responders","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2018-09-03","conditions":"Fertility Disorders","enrollment":88},{"nctId":"NCT04453332","phase":"NA","title":"Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters","status":"UNKNOWN","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2015-10-09","conditions":"Menopause, Hormone Replacement Therapy","enrollment":60},{"nctId":"NCT03938064","phase":"PHASE4","title":"Timing of Initiation of Luteal Phase Support in Poor Responders Undergoing IVF/ICSI","status":"UNKNOWN","sponsor":"Ain Shams Maternity Hospital","startDate":"2019-06-26","conditions":"Infertility","enrollment":520},{"nctId":"NCT01744574","phase":"NA","title":"Sex Differences, Hormones & Smoking Cessation","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2012-12","conditions":"Tobacco Cessation","enrollment":216},{"nctId":"NCT02118051","phase":"PHASE3","title":"Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response.","status":"COMPLETED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2013-09","conditions":"Infertility","enrollment":234},{"nctId":"NCT03058536","phase":"PHASE2, PHASE3","title":"Progesterone and Cervical Pessary in Twins","status":"UNKNOWN","sponsor":"Mario Henrique Burlacchini de Carvalho","startDate":"2017-02-21","conditions":"Preterm Birth, Twin Pregnancy With Antenatal Problem","enrollment":312},{"nctId":"NCT01798394","phase":"NA","title":"Progesterone & Postpartum Relapse to Smoking","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2014-06","conditions":"Tobacco Use Cessation, Tobacco Use Disorder","enrollment":46},{"nctId":"NCT02620124","phase":"PHASE4","title":"GnRH Agonist as Luteal Support in FET Cycles","status":"COMPLETED","sponsor":"Turku University Hospital","startDate":"2013-05","conditions":"Infertility","enrollment":100},{"nctId":"NCT02690129","phase":"NA","title":"Vaginal Progesterone for Treatment of Threatened Miscarriage","status":"UNKNOWN","sponsor":"Omar Mamdouh Shaaban","startDate":"2016-02","conditions":"Threatened Miscarriage","enrollment":290},{"nctId":"NCT01353846","phase":"PHASE4","title":"Comparison Between Natural and Artificial Cycle in Recipient Oocyte Patients","status":"UNKNOWN","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2011-05","conditions":"Infertility","enrollment":70},{"nctId":"NCT00864214","phase":"PHASE1","title":"A Pharmacokinetic Evaluation of Bioidentical Compounded Estrogen Cream and Natural Progesterone","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2008-06","conditions":"Menopause","enrollment":40},{"nctId":"NCT01123538","phase":"PHASE4","title":"Progestagen Type in Postmenopausal Hormone Therapy and Blood Gene Expression Profile","status":"UNKNOWN","sponsor":"University Hospital of North Norway","startDate":"2008-12","conditions":"Pharmacogenomics, Systems Biology","enrollment":40}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["PROGEFFIK®."],"phase":"phase_3","status":"active","brandName":"Micronized natural progesterone.","genericName":"Micronized natural progesterone.","companyName":"Instituto de Investigacion Sanitaria La Fe","companyId":"instituto-de-investigacion-sanitaria-la-fe","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Micronized natural progesterone binds to progesterone receptors throughout the body to exert hormonal effects on the endometrium, breast, and other reproductive tissues. Used for Endometrial protection in hormone replacement therapy, Luteal phase support / progesterone supplementation, Menopause-related symptoms.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}